GraftCath Raises $12 Million

GraftCath Inc., an Eden Prairie, Minn.-based, has raised $12 million in Series D funding, according to VentureWire. Affinity Capital Management led the round, and was joined by Ascension Health Ventures and return backers Cutlass Capital, Sapient Capital and Three Arch Partners.

Existing shareholder Boston Scientific did not participate, because it recently sold off its vascular surgery business.